Condition: Healthy Subjects · Sponsor: NeuShen Therapeutics
The goal of this clinical trial is to exlplore the profile of NS-136 in health conditions. The main questions it aims to answer are: * Is NS-136 safe and tolerable in heathy subjects under tested dosing regimen? * What is the pharmacokinectic profile of NS-136 in healthy subjects under tested dosing regimen?
This description comes directly from the study's public registry record.
Chao Zhang, PhD · 8613918282581 · chao.zhang@neushen.com
Yangyi Qu, MS · 8613262952232 · yangyi.qu@neushen.com
Always discuss trial participation with your own doctor first.
| CMAX Clinical Research Pty Ltd | Adelaide, South Australia, Australia | Recruiting |
| Chengdu Xinhua Hospital | Chengdu, Sichuan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06345703